| Monofer (iron isomaltoside 1000) / Pharmacosmos |
| Completed | 3 | 350 | Europe, RoW | Monofer, Iron Sulphate | Pharmacosmos A/S, Max Neeman International | Inflammatory Bowel Disease | 07/12 | 08/12 | | |
NCT01145638 / 2009-016727-53: A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA) |
|
|
| Completed | 3 | 350 | RoW | iron isomaltoside 1000, Monofer, iron sulphate, Ferroduretter | Pharmacosmos A/S | Non-myeloid Malignancies, Chemotherapy Induced Anaemia | 04/14 | 05/14 | | |
| Completed | 3 | 351 | Europe | Monofer, Iron Sulphate | Pharmacosmos A/S | Iron Deficiency Anemia, Chronic Kidney Disease | 06/14 | 06/14 | | |
| Withdrawn | 3 | 0 | US | Iron isomaltoside 1000, Natrium Chloride 0,9% | Pharmacosmos A/S | Iron Deficiency Anemia | 03/15 | | | |
NCT02130063: IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose |
|
|
| Completed | 3 | 511 | US | iron isomaltoside 1000 (Monofer®), iron sucrose (Venofer®) | Pharmacosmos A/S, BioStata, ClinStar, LLC, Laboratory Corporation of America | Iron Deficiency Anaemia | 08/15 | 08/15 | | |
| Completed | 3 | 107 | Europe | Iron isomaltoside 1000 (Monofer®), Monofer®, Placebo, 0.9 % saline | Pharmacosmos A/S, Max Neeman | Iron-deficiency | 12/16 | 12/16 | | |
